Pay in 4 interest-free payments of $7.18 Learn more
Ships within 48 hours · Estimated delivery Oct 2 - Oct 7
doi: 10.1038/s42255-023-00859-y, 60 HarastaA
View Source LANCET DIABETES & ENDOCRINOLOGY Effects of retatrutide on body composition in people with type 2 diabetes 2025 Coskun T, et al
Looking from 2023 to 2024, the latest year of data available, prescriptions and gross spending for Wegovy (first approved for obesity in 2021, approved for cardiovascular disease in 2024) and Mounjaro (approved for type 2 diabetes in 2022) more than doubled, and prescriptions and gross spending for Zepbound (first approved for obesity in 2023, approved for sleep apnea in 2024) increased more than fivefold
1 Introduction Atherosclerosis is a chronic metabolic and inflammatory disorder marked by endothelial dysfunction, lipid oxidation, immune cell recruitment, and plaque formation ( Table 1 Summary of the effects of GLP-1 receptor agonists (GLP-1RA) on discussed biomarkers
US$ 20.72
US$ 20.68
US$ 28.81
US$ 21.26
US$ 29.19
